Healthcare provider profile · identity verified

Sowmya Srimanthula, MD

Internal Medicine · SOUTH BOSTON, VA · NPI 1174019996

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	520	144
Atorvastatin Calcium	Atorvastatin Calcium	492	157
Metformin Hcl	Metformin Hcl	321	97
Levothyroxine Sodium	Levothyroxine Sodium	292	77
Lisinopril	Lisinopril	264	79
Losartan Potassium	Losartan Potassium	242	59
Gabapentin	Gabapentin	240	68
Pantoprazole Sodium	Pantoprazole Sodium	211	66
Rosuvastatin Calcium	Rosuvastatin Calcium	182	48
Hydrochlorothiazide	Hydrochlorothiazide	172	47
Albuterol Sulfate Hfa	Albuterol Sulfate	149	40
Pravastatin Sodium	Pravastatin Sodium	148	41
Simvastatin	Simvastatin	148	40
Allopurinol	Allopurinol	146	41
Tamsulosin Hcl	Tamsulosin Hcl	145	45
Omeprazole	Omeprazole	133	43
Potassium Chloride	Potassium Chloride	132	38
Furosemide	Furosemide	128	38
Fluticasone Propionate	Fluticasone Propionate	111	46
Metoprolol Tartrate	Metoprolol Tartrate	108	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	106	34
Metoprolol Succinate	Metoprolol Succinate	104	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	97	28
Montelukast Sodium	Montelukast Sodium	96	26
Trazodone Hcl	Trazodone Hcl	95	32
Glimepiride	Glimepiride	94	30
Metformin Hcl Er	Metformin Hcl	87	28
Carvedilol	Carvedilol	80	22
Clopidogrel	Clopidogrel Bisulfate	78	21
Ozempic	Semaglutide	75	14
Atenolol	Atenolol	73	19
Duloxetine Hcl	Duloxetine Hcl	72	22
Mirtazapine	Mirtazapine	72	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	19
Glipizide	Glipizide	64	15
Glipizide Er	Glipizide	64	15
Pregabalin	Pregabalin	64	11
Baclofen	Baclofen	60	29
Alendronate Sodium	Alendronate Sodium	59	21
Famotidine	Famotidine	59	15
Prednisone	Prednisone	59	47
Alprazolam	Alprazolam	58	15
Diclofenac Sodium	Diclofenac Sodium	58	29
Ezetimibe	Ezetimibe	56	13
Sertraline Hcl	Sertraline Hcl	56	19
Jardiance	Empagliflozin	55	15
Triamcinolone Acetonide	Triamcinolone Acetonide	55	21
Escitalopram Oxalate	Escitalopram Oxalate	53	11
Tizanidine Hcl	Tizanidine Hcl	53	20
Benazepril Hcl	Benazepril Hcl	49	suppressed
Januvia	Sitagliptin Phosphate	46	15
Spironolactone	Spironolactone	46	12
Meloxicam	Meloxicam	45	17
Quetiapine Fumarate	Quetiapine Fumarate	43	11
Hydralazine Hcl	Hydralazine Hcl	41	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Olanzapine	Olanzapine	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	11
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	12
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Ondansetron Odt	Ondansetron	34	14
Hydroxyzine Hcl	Hydroxyzine Hcl	33	11
Topiramate	Topiramate	33	13
Dexlansoprazole Dr	Dexlansoprazole	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Cefdinir	Cefdinir	30	29
Donepezil Hcl	Donepezil Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	25
Fenofibrate	Fenofibrate	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Eliquis	Apixaban	24	suppressed
Valsartan	Valsartan	24	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Nystatin	Nystatin	21	suppressed
Finasteride	Finasteride	20	suppressed
Fluconazole	Fluconazole	20	13
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Novolog Flexpen	Insulin Aspart	18	11
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Ramipril	Ramipril	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	17	suppressed
Colchicine	Colchicine	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Azithromycin	Azithromycin	14	13
Cephalexin	Cephalexin	14	11
Doxepin Hcl	Doxepin Hcl	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	12
Mupirocin	Mupirocin	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Primidone	Primidone	12	suppressed
Torsemide	Torsemide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error